Next Article in Journal
Toxicity-Induced Discontinuation of Immune Checkpoint Inhibitors in Metastatic Urothelial Cancer: 6-Year Experience from a Specialized Uro-Oncology Center
Next Article in Special Issue
Is There an Opportunity to De-Escalate Treatments in Selected Patients with Metastatic Hormone-Sensitive Prostate Cancer?
Previous Article in Journal
The Impact of Urine-Sample HPV Testing on the Effectiveness of Screening for Cervical Cancer: An Umbrella Review
Previous Article in Special Issue
Diagnostic Biomarkers in Renal Cell Tumors According to the Latest WHO Classification: A Focus on Selected New Entities
 
 
Article

Article Versions Notes

Cancers 2024, 16(12), 2245; https://doi.org/10.3390/cancers16122245
Action Date Notes Link
article pdf uploaded. 17 June 2024 17:53 CEST Version of Record https://www.mdpi.com/2072-6694/16/12/2245/pdf-vor
article supplementary file uploaded. 17 June 2024 17:53 CEST - https://www.mdpi.com/2072-6694/16/12/2245#supplementary
article xml file uploaded 20 June 2024 03:31 CEST Original file -
article xml uploaded. 20 June 2024 03:31 CEST Update https://www.mdpi.com/2072-6694/16/12/2245/xml
article pdf uploaded. 20 June 2024 03:31 CEST Updated version of record https://www.mdpi.com/2072-6694/16/12/2245/pdf
article html file updated 20 June 2024 03:33 CEST Original file https://www.mdpi.com/2072-6694/16/12/2245/html
Back to TopTop